Multiple Myeloma Autologous Stem Cell Transplant

Stem cell transplant for multiple myeloma.

Multiple myeloma autologous stem cell transplant. When stem cell transplants were first developed the new stem cells came from bone marrow and so this was known as a bone marrow. We here analyze factors influencing survival in 865 newly diagnosed mm patien. Autologous stem cell transplant multiple myeloma time factors abstract as multiple myeloma mm treatments evolve frequent updates are required to monitor the long term effect of changes in approach. It isn t a cure but compared to chemotherapy alone a.

The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival. A stem cell transplant replaces unhealthy blood cells with healthy ones. Since high dose treatment destroys the normal bone marrow in addition to the myeloma cells the collected stem cells are unfrozen and given back into the bloodstream through an intravenous into a vein catheter one to two days after administration of the high dose chemotherapy. Then the patient receives new healthy blood forming stem cells.

Autologous and allogeneic stem cell transplants. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. A stem cell transplant in combination with high dose chemotherapy is a treatment option that offers a chance for durable remission for people with multiple myeloma.